DNAJC28 and bacterial infectious disease: Endolysins, i.e. lytic enzymes of phage origin (e.g. MLE-15 created by VersaTile methodology) are currently facing great interest in the context of the therapy of bacterial infections (e.g. LysRODI against S. aureus59, Ph28 against S. epidermidis60, ORF28 gene product against E. faecalis61).